Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/23224Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kalogeraki, A. | en |
| dc.contributor.author | Tzardi, M. | en |
| dc.contributor.author | Datseris, G. | en |
| dc.contributor.author | Kanavaros, P. | en |
| dc.contributor.author | Karvelas, C. | en |
| dc.contributor.author | Chalkiadakis, G. | en |
| dc.contributor.author | Tsiftsis, D. | en |
| dc.contributor.author | Delides, G. | en |
| dc.date.accessioned | 2015-11-24T19:31:11Z | - |
| dc.date.available | 2015-11-24T19:31:11Z | - |
| dc.identifier.issn | 0250-7005 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/23224 | - |
| dc.rights | Default Licence | - |
| dc.subject | Breast Neoplasms/*chemistry/pathology | en |
| dc.subject | Female | en |
| dc.subject | Fibroadenoma/chemistry/pathology | en |
| dc.subject | Fibrocystic Breast Disease/chemistry/pathology | en |
| dc.subject | Humans | en |
| dc.subject | Receptor, erbB-2/*analysis | en |
| dc.title | C-erbB-2: expression in patients with breast carcinoma in comparison to patients with benign breast diseases | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/8687126 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 1996 | - |
| heal.abstract | C-erbB-2 (Her-2 or c-neu) expression was studied by immunohistochemistry on FNA specimens of 20 breast ductal carcinomas, 20 fibroadenomas and 20 atypical fibrocystic lesions of the breast. Twelve cases of breast carcinomas, six fibroadenomas and five atypical fibrocystic lesions were found to display c-erbB-2 staining. A significant difference was found among c-erbB-2 index of breast carcinomas (mean 70,25), fibroadenomas (mean 43,83) and atypical fibrocystic disease (mean 37,4). We also found variations in c-erbB-2 expression, among individual cases of breast carcinomas, concerning the number and the intensity of carcinoma cells. It would be interesting to correlate these variations in c-erbB-2 expression with the prognosis of breast carcinomas. | en |
| heal.journalName | Anticancer Res | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
